ArticleInternational journal of clinical and health psychology : IJCHP
The acceptability of virtual reality mindfulness for the treatment of insomnia: clinicians and patients' attitudes.
Article in International journal of clinical and health psychology : IJCHP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Virtual reality combined with biofeedback improves sleep quality and daytime function in patients with chronic insomnia.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insomnia is a prevalent condition with substantial health, economic, and societal burden. Despite evidence supporting the use of cognitive behavioural therapy for insomnia (CBTi) accessibility remains limited, shows high dropout rates, and is ineffective for 30 % of patients. Virtual reality (VR) mindfulness offers a novel, engaging, and scalable alternative, with the potential for enhanced treatment adherence compared to other digital health interventions (e.g., apps, audio, and online programs). VR has demonstrated efficacy in treating conditions such as chronic pain, anxiety, and depression, disorders often co-occurring with insomnia, its potential for treating insomnia remains underexplored. Aims: This study aimed to (1) assess the acceptability of VR mindfulness for the treatment of insomnia from clinicians and patients with chronic insomnia, and (2) identify barriers and facilitators to its adoption and clinical implementation. Methods: A mixed-methods design was used, including a questionnaire assessing familiarity with digital health technologies (DHTs) and the perceived utility of VR mindfulness for insomnia, followed by a 2-h in-person focus group. Participants explored and evaluated four VR mindfulness applications. The convenience sample included (1) community-dwelling adults with chronic insomnia (ISI > 10, PSQI > 10) and (2) clinicians registered with the Australian Health Practitioner Regulation Agency (AHPRA) familiar with insomnia treatment. Focus group data were analysed using thematic analysis and inductive reasoning. Results: 19 patients (14 F, 4 M; mean age 46.26 ± 9.19 years) with moderate-to-severe chronic insomnia (mean ISI 17.48 ± 4.29; mean PSQI 14.46 ± 4.22) and 14 clinicians (9 F, 5 M; mean age 43.93 ± 12.01 years) with an average of 15 ± 12.28 years of experience participated. 72.8 % expressed curiosity and 36.4 % excitement at the prospect of trying VR mindfulness; 36.8 % of patients and 57.1 % of clinicians stated prior experience with VR; all welcomed the possibility of a new treatment for insomnia; VR mindfulness was described as Conclusion: VR mindfulness is an acceptable, engaging, and scalable treatment for insomnia, with potential for rapid clinical adoption. Further research demonstrating its feasibility and efficacy are important first steps to integration into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.